Literature DB >> 3598347

Effects of a vitamin K-deficient diet and antibiotics in normal human volunteers.

P M Allison, L L Mummah-Schendel, C G Kindberg, C S Harms, N U Bang, J W Suttie.   

Abstract

Decreased concentrations of vitamin K-dependent plasma clotting factors are a well-documented response of vitamin K-deprived patients administered broad-spectrum antibiotics. It has recently been claimed that antibiotics containing a N-methylthiotetrazole (NMTT) side chain cause this response through a direct effect of NMTT on the vitamin K-dependent posttranslational carboxylation of these clotting factors. To further study these relationships, 11 groups of three volunteers were fed a synthetic vitamin K-free diet for 2 weeks. During the last 10 days of vitamin K restriction, seven of the volunteer groups received a therapeutic dose of antibiotics not containing NMTT: ampicillin, sulfamethoxazole-trimethoprim (Bactrim), cefoxitin, cefotaxime, ceftazidime, clindamycin, and piperacillin, and three groups received NMTT-containing antibiotics: moxalactam, cefamandole, and cefoperazone. Serum phylloquinone (vitamin K1) concentrations reflected dietary intake and fell from 1.4 +/- 0.9 ng/ml after 3 days of hospital diet to 0.4 +/- 0.3 ng/ml after 13 days of vitamin K-free diet. Median stool excretion of phylloquinone was 19 micrograms/day while subjects consumed the hospital diet, and fell to 3 micrograms/day by day 6 on vitamin K-free diet. Prothrombin times remained within the normal range throughout the study. Suppression of vitamin K-dependent clotting factor biosynthesis was evident by decreased factor VII levels in seven of the volunteers and by an increased concentration of des-gamma-carboxy (abnormal) prothrombin in 21 of the volunteers. The changes occurred in the control subjects and in subjects receiving all nine of the 10 antibiotics with no consistent pattern.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3598347

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  7 in total

Review 1.  Vitamin K in CKD Bone Disorders.

Authors:  M Fusaro; G Cianciolo; P Evenepoel; L Schurgers; M Plebani
Journal:  Calcif Tissue Int       Date:  2021-01-06       Impact factor: 4.333

2.  Effect of phylloquinone supplementation on glucose homeostasis in humans.

Authors:  Rajiv Kumar; Neil Binkley; Adrian Vella
Journal:  Am J Clin Nutr       Date:  2010-09-29       Impact factor: 7.045

3.  Dietary induced subclinical vitamin K deficiency in normal human subjects.

Authors:  G Ferland; J A Sadowski; M E O'Brien
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

4.  Establishing a rat model for the study of vitamin K deficiency.

Authors:  Yanni Mi; Xue Xiao; Dongzheng Liu; Nana Ping; Yanbing Zhu; Bo Li; Lihui Long; Yongxiao Cao
Journal:  Int J Exp Pathol       Date:  2016-06-03       Impact factor: 1.925

5.  Cefoperazone/Sulbactam-Induced Abdominal Wall Hematoma and Upper Gastrointestinal Bleeding: A Case Report and Review of the Literature.

Authors:  ZhuYing Cai; Wei Yang; YingYing He; Qingge Chen; ShiQiang Wang; Xuming Luo; Xiongbiao Wang
Journal:  Drug Saf Case Rep       Date:  2016-12

Review 6.  The Role of Gut Dysbiosis in the Bone-Vascular Axis in Chronic Kidney Disease.

Authors:  Pieter Evenepoel; Sander Dejongh; Kristin Verbeke; Bjorn Meijers
Journal:  Toxins (Basel)       Date:  2020-04-29       Impact factor: 4.546

7.  Sevelamer Use in End-Stage Kidney Disease (ESKD) Patients Associates with Poor Vitamin K Status and High Levels of Gut-Derived Uremic Toxins: A Drug-Bug Interaction?

Authors:  Lu Dai; Björn K Meijers; Bert Bammens; Henriette de Loor; Leon J Schurgers; Abdul Rashid Qureshi; Peter Stenvinkel; Pieter Evenepoel
Journal:  Toxins (Basel)       Date:  2020-05-27       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.